Steward Partners Investment Advisory, LLC Medi Wound Ltd. Transaction History

Steward Partners Investment Advisory, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.35 - $2.24 $1,350 - $2,240	-1,000 Reduced 40.0%	1,500 $2,000
Q4 2021 Feb 08, 2022	SELL	$2.2 - $4.01 $1,100 - $2,005	-500 Reduced 16.67%	2,500 $6,000
Q2 2021 Aug 13, 2021	SELL	$3.38 - $5.71 $3,380 - $5,710	-1,000 Reduced 25.0%	3,000 $11,000
Q1 2021 May 14, 2021	BUY	$3.77 - $6.05 $3,770 - $6,050	1,000 Added 33.33%	4,000 $21,000
Q3 2020 Oct 30, 2020	SELL	$3.09 - $4.14 $1,081 - $1,449	-350 Reduced 10.45%	3,000 $11,000

Q3 2019 Oct 30, 2019	SELL	$2.58 - $3.97 $8,514 - $13,101	-3,300 Reduced 49.62%	3,350 $10,000
Q2 2019 Jul 25, 2019	BUY	$3.0 - $5.5 $19,950 - $36,575	6,650 New	6,650 $22,000
Q4 2018 Jan 15, 2019	SELL	$3.95 - $6.55 $13,825 - $22,925	-3,500 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$6.1 - $7.1 $21,350 - $24,850	3,500 New	3,500 $22,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $789M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.